Back to Feed
总结
多家媒体报道，印度知名投资者Vijay Kedia通过大宗交易买入微盘制药企业Mangalam Drugs & Organics股份，涉资约330万卢比（约33 lakh）。交易消息公布后，该股在交易日内触及5%涨停，并在两天内累计上涨约10%。报道同时指出，该公司股价在过去一年曾下跌逾70%，此次买入被视为其新增持仓。市场对投资者入场的关注推动短期股价波动，并提升该股的交易热度与讨论度。
正文
Stake Buy: Vijay Kedia buys stake worth ₹33 Lakhs in this penny stock; Shares hit 5% upper circuit Trade Brains Vijay Kedia picks stake in microcap pharma firm; stock jumps 10% in 2 days MSN Mangalam Drugs Bulk Deal: Vijay Kedia's new bet is a microcap that has plunged over 70% in one year The Economic Times Mangalam Drugs shares hit 5% upper circuit after Vijay Kedia buys stake worth Rs 33 lakh Moneycontrol Mangalam Drugs & Organics shares hits 5% upper circuit; here's why Business Standard
发布时间：